RGD targeting moiety its porduction and use

Details for Australian Patent Application No. 2004295126 (hide)

Owner Pharmexa A/S

Inventors Hollig, Peter; Kontermann, Roland

Agent Pizzeys

Pub. Number AU-A-2004295126

PCT Pub. Number WO2005/054293

Priority 03027943.4 04.12.03 EP

Filing date 6 December 2004

Wipo publication date 16 June 2005

International Classifications

C07K 1/04 (2006.01) General processes for the preparation of peptides

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/78 (2006.01) Peptides having more than 20 amino acids

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/054293 Priority application(s): WO2005/054293

11 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004295132-Method for synthesis of perindopril and the pharmaceutically-acceptable salts thereof

2004295105-Nitrooxyderivatives of antihypertensive drugs